P

Insulet Corp
D

PODD

262.00
USD
-4.53
(-1.70%)
Market Closed
Volume
48,154
EPS
3
Div Yield
-
P/E
47
Market Cap
18,370,256,284
Related Instruments
    ABT
    ABT
    0.850
    (0.74%)
    117.25 USD
    BSX
    BSX
    -0.590
    (-0.67%)
    87.000 USD
    DXCM
    DXCM
    1.195
    (1.60%)
    75.890 USD
    EW
    EW
    1.620
    (2.45%)
    67.780 USD
    ISRG
    ISRG
    -10.30
    (-1.92%)
    550.64 USD
    MDT
    MDT
    1.520
    (1.77%)
    84.75 USD
    PFE
    PFE
    -1.225
    (-4.71%)
    25.14 USD
    T
    TFX
    1.430
    (0.75%)
    192.190 USD
    T
    TNDM
    -1.240
    (-4.34%)
    27.330 USD
    Z
    ZBH
    3.638
    (3.34%)
    112.490 USD
    More
News

Title: Insulet Corp

Sector: Healthcare
Industry: Medical Devices
Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device and that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the U.S. Food and Drug Administration in 2005, approximately 425,000 insulin-dependent diabetics are using it worldwide.